New dual-purpose contrast agent revolutionizes PET and MRI integration for enhanced diagnosis

A research team from IOCB Prague, working in collaboration with the University of Tübingen, Germany, and the Faculty of Science, Charles University, has developed a new type of contrast agent that can be used in both magnetic resonance imaging (MRI) and positron emission tomography (PET).

“NK cell-engaging nanodrones” can selectively target and kill cancer cells

A groundbreaking study led by Professor Sebyung Kang and Professor Sung Ho Park in the Department of Biological Sciences at UNIST has unveiled a remarkable

December 30, 2023

Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO – Biotech Investments

PolyPeptide Group / Key word(s): Half Year Results 15-Aug-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

August 16, 2023

Patients With Narcolepsy Face Mood and Pain Disorders

NASHVILLE, Tenn. — People with narcolepsy frequently had mood and pain comorbidities that complicated diagnosis and treatment plans, observational data showed. In a propensity-matched cohort

September 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.